MBS Review Taskforce meeting outcomes, 2 August 2018

On 2 August 2018, the Medicare Benefits Schedule (MBS) Review Taskforce (the Taskforce) held its 33rd meeting. The following is a summary of the outcomes arising from the meeting.

Page last updated: 11 April 2019

PDF version: MBS Review Taskforce meeting outcomes, 2 August 2018 (PDF 89 KB)

Diagnostic Imaging Clinical Committee

The Taskforce endorsed the Diagnostic Imaging Clinical Committee 10th Report (MRI) for consultation.

New recommendations from Diagnostic Imaging Clinical Committee

The Taskforce endorsed several items from the list of ten recommendations for consultation.

Pathology Clinical Committee Report: Blood Products

The Taskforce endorsed for consultation the Pathology Clinical Committee Report on Blood Products.

Neurosurgery & Neurology Clinical Committee Report

The Taskforce endorsed the Neurosurgery & Neurology Clinical Committee Report with amendments for consultation.

Urology Clinical Committee Report

The Taskforce endorsed the Urology Clinical Committee Report for consultation.

General Practice and Primary Care Clinical Committee Report

The Taskforce endorsed the release of the General Practice and Primary Care Clinical Committee Phase 1 and Phase 2 Reports for consultation.

Diagnostic Medicine Clinical Committee

The Taskforce endorsed the amendments to the recommendations on iron studies, ferritin and folate items.

Principles for Standby Services – Cardiac

The Taskforce endorsed items to be provided to Government for consideration.